Alpha 2.0
Login Register
» Articles » PMID: 33220078

The Value of Subcutaneous Vs. Oral Methotrexate: Real-world Data from the German Psoriasis Registry PsoBest

Overview
Journal Br J Dermatol
Publisher Oxford University Press
Specialty Dermatology
Date 2020 Nov 21
PMID 33220078
Citations 5
Authors
K Reich
C Sorbe
L Griese
J L K Reich
M Augustin
Affiliations
Soon will be listed here.
Citing Articles

Pathophysiology and Treatment of Psoriasis: From Clinical Practice to Basic Research.

Gao Y, Xu T, Wang Y, Hu Y, Yin S, Qin Z Pharmaceutics. 2025; 17(1).

PMID: 39861704 PMC: 11769081. DOI: 10.3390/pharmaceutics17010056.

International Survey to Evaluate Current Options for Subcutaneous Injection of Methotrexate (MTX) and a New Button-Free MTX Autoinjector.

Muller-Ladner U, Edwards C, Erkens A Patient Prefer Adherence. 2024; 18:579-590.

PMID: 38463400 PMC: 10924829. DOI: 10.2147/PPA.S440818.

Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus.

Damiani G, Amerio P, Bardazzi F, Carrera C, Conti A, Cusano F Dermatol Ther (Heidelb). 2023; 13(6):1219-1241.

PMID: 37210684 PMC: 10200012. DOI: 10.1007/s13555-023-00930-2.

.

Pompilio G, Integlia D Glob Reg Health Technol Assess. 2023; 9:138-145.

PMID: 36628309 PMC: 9668062. DOI: 10.33393/grhta.2022.2474.

Methotrexate injection site reactions: Case report and literature review.

Kaur J, Zambito J, Richardson C JAAD Case Rep. 2022; 23:79-82.

PMID: 35465137 PMC: 9024377. DOI: 10.1016/j.jdcr.2022.02.030.